An artificial pancreatic system under closed-loop from Tandem

An artificial pancreatic system under closed-loop from Tandem

An ongoing clinical research and trial program for an artificial pancreas system registered very promising results. In studies, an artificial pancreas system shows that it can be used in the treatment for people with type 1 diabetes. It is also stated that it can help to manage the level of blood sugar for overnight as well as throughout the day. The closed-loop system mechanically supplies the hormone to the human body based on readings and other data for blood sugar. This doesn’t need daily injections, or fingerstick draws. This closed-loop system consists of Dexcom’s G6 continuous glucose monitor, which is linked with T: slim X2 of Tandem Diabetes Care, an alternate controller-enabled insulin pump.

The clinical trial was a part of the International Diabetes Closed-Loop study which is funded by the National Institute of Health (NIH). This study was conducted for six months in which around 166 patients had enrolled having age of 14 and above. While conducting the survey, participant received sensor-augmented pump and CGM combination, dubbed Control-IQ, or artificial pancreas system. A researcher found that the Control-IQ system performed superior by maintaining sugar levels of participants inside a healthy series—by an average of 2.6 hours per day, further associated with the initial phase of the study. However, the control group displayed no improvements in time.

In addition, artificial pancreatic users have less time to increase or decrease their blood glucose within 24 hours. This can be a challenge for children and adults with type 1 diabetes in sleep. Boris Kovachev, director of the Diabetes Technology Center, University of Virginia, said that this artificial pancreatic system has numerous unique characteristics that can increase glucose control what traditional methods can achieve. The first author of the study helped in developing the algorithms for the Control-IQ system. He added that there is a special module for safety to prevent hypoglycemia. It gradually strengthens the control overnight, so that the blood sugar level is close to normal every morning.